All Stories

  1. Case Report: Rubella Virus-Induced Cutaneous Granulomas in Two Pediatric Patients With DNA Double Strand Breakage Repair Disorders – Outcome After Hematopoietic Stem Cell Transplantation

    Article • Frontiers in Immunology, June 2022, Frontiers

    Oliver Blankenstein

  2. Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe

    Article • European Journal of Endocrinology, May 2022, Oxford University Press (OUP)

    Oliver Blankenstein

  3. Treatment of congenital adrenal hyperplasia in children aged 0–3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure

    Article • European Journal of Endocrinology, May 2022, Oxford University Press (OUP)

    Oliver Blankenstein

  4. Exploring Dried Blood Spot Cortisol Concentrations as an Alternative for Monitoring Pediatric Adrenal Insufficiency Patients: A Model-Based Analysis

    Article • Frontiers in Pharmacology, March 2022, Frontiers

    Oliver Blankenstein

  5. Simultaneous newborn screening for sickle cell disease, biotinidase deficiency, and hereditary tyrosinemia type 1 with an optimized tandem mass spectrometry protocol

    Article • Annals of Hematology, March 2022, Springer Science + Business Media

    Oliver Blankenstein

  6. Reply: 68Ga NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication

    Article • Journal of Nuclear Medicine, March 2022, Society of Nuclear Medicine

    Oliver Blankenstein

  7. Severe Acquired Primary Hypothyroidism in Children and its Influence on Growth: A Retrospective Analysis of 43 Cases

    Article • Experimental and Clinical Endocrinology & Diabetes, October 2021, Thieme Publishing Group

    Oliver Blankenstein

  8. Rationale of a lower dexamethasone dose in prenatal congenital adrenal hyperplasia therapy based on pharmacokinetic modelling

    Article • European Journal of Endocrinology, September 2021, Oxford University Press (OUP)

    Oliver Blankenstein

  9. 68Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism

    Article • Journal of Nuclear Medicine, July 2021, Society of Nuclear Medicine

    Oliver Blankenstein

  10. International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia: data from the I-CAH registry

    Article • European Journal of Endocrinology, April 2021, Oxford University Press (OUP)

    Oliver Blankenstein, Professor Berenice B Mendonca

  11. Neonatal Screening for Congenital Metabolic and Endocrine Disorders

    Article • Deutsches Ärzteblatt international, February 2021, Deutscher Arzte-Verlag GmbH

    Oliver Blankenstein

  12. Open-Source Technology for Real-Time Continuous Glucose Monitoring in the Neonatal Intensive Care Unit: Case Study in a Neonate With Transient Congenital Hyperinsulinism

    Article • Journal of Medical Internet Research, December 2020, JMIR Publications Inc.

    Oliver Blankenstein

  13. Response to ‘Hydrocortisone suspension formulations are not necessarily the same in the treatment of children with congenital adrenal hyperplasia’

    Article • European Journal of Endocrinology, December 2020, Oxford University Press (OUP)

    Oliver Blankenstein

  14. Newborn Screening for SCID and Other Severe Primary Immunodeficiency in the Polish-German Transborder Area: Experience From the First 14 Months of Collaboration

    Article • Frontiers in Immunology, October 2020, Frontiers

    Oliver Blankenstein

  15. Paediatric population pharmacokinetic modelling to assess hydrocortisone replacement dosing regimens in young children

    Article • European Journal of Endocrinology, October 2020, Oxford University Press (OUP)

    Oliver Blankenstein

  16. Real-World Estimates of Adrenal Insufficiency–Related Adverse Events in Children With Congenital Adrenal Hyperplasia

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2020, Endocrine Society

    Oliver Blankenstein, Professor Berenice B Mendonca

  17. A Prospective Study of Children Aged 0–8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2020, Endocrine Society

    Oliver Blankenstein

  18. Auswirkungen der SARS-CoV-2 Pandemie auf die Früherkennungs-Untersuchungen bei Kindern

    Article • Klinische Pädiatrie, September 2020, Thieme Publishing Group

    Oliver Blankenstein

  19. Comparative meta‐analysis of Kabuki syndrome with and without hyperinsulinaemic hypoglycaemia

    Article • Clinical Endocrinology, July 2020, Wiley

    Oliver Blankenstein

  20. Open-Source Technology for Real-Time Continuous Glucose Monitoring in the Neonatal Intensive Care Unit: Case Study in a Neonate With Transient Congenital Hyperinsulinism (Preprint)

    Article • July 2020, JMIR Publications Inc.

    Oliver Blankenstein

  21. Hyperinsulinismus

    Article • November 2019, Springer Science + Business Media

    Oliver Blankenstein

  22. Therapeutische Optionen bei konnataler Zytomegalievirus (CMV)-Infektion – Implikationen für die Einführung eines Screeningprogramms

    Article • Zeitschrift für Geburtshilfe und Neonatologie, August 2019, Thieme Publishing Group

    Oliver Blankenstein

  23. Sleep Timing in Patients with Precocious and Delayed Pubertal Development

    Article • Clocks & Sleep, February 2019, MDPI AG

    Oliver Blankenstein

  24. Characterization of diabetes following pancreatic surgery in patients with congenital hyperinsulinism

    Article • Orphanet Journal of Rare Diseases, December 2018, Springer Science + Business Media

    Oliver Blankenstein

  25. Newborn screening by tandem mass spectrometry confirms the high prevalence of sickle cell disease among German newborns

    Article • Annals of Hematology, August 2018, Springer Science + Business Media

    Oliver Blankenstein

  26. MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency

    Article • Nature Reports Stem Cells, May 2018, Springer Science + Business Media

    Oliver Blankenstein

  27. Mean High-Dose l-Thyroxine Treatment Is Efficient and Safe to Achieve a Normal IQ in Young Adult Patients With Congenital Hypothyroidism

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2018, Endocrine Society

    Oliver Blankenstein

  28. Hyperinsulinismus

    Article • January 2018, Springer Science + Business Media

    Oliver Blankenstein

  29. Primary sulphonylurea therapy in a newborn with transient neonatal diabetes attributable to a paternal uniparental disomy 6q24 (UPD6)

    Article • Diabetes Obesity and Metabolism, October 2017, Wiley

    Oliver Blankenstein

  30. Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency

    Article • Clinical Endocrinology, September 2017, Wiley

    Martin Whitaker, Oliver Blankenstein

  31. Real-life GH dosing patterns in children with GHD, TS or born SGA: a report from the NordiNet® International Outcome Study

    Article • European Journal of Endocrinology, May 2017, Bioscientifica

    Oliver Blankenstein

  32. Quality of compounded hydrocortisone capsules used in the treatment of children

    Article • European Journal of Endocrinology, May 2017, Bioscientifica

    Oliver Blankenstein

  33. Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans

    Article • Journal of Clinical Investigation, March 2017, American Society for Clinical Investigation

    Oliver Blankenstein

  34. Is safety of childhood growth hormone therapy related to dose? Data from a large observational study

    Article • European Journal of Endocrinology, March 2017, Oxford University Press (OUP)

    Oliver Blankenstein

  35. Functional Implications of LH/hCG Receptors in Pregnancy-Induced Cushing Syndrome

    Article • Journal of the Endocrine Society, January 2017, Endocrine Society

    Ilpo Huhtaniemi, Oliver Blankenstein

  36. How to improve information extraction from German medical records

    Article • it - Information Technology, January 2017, De Gruyter

    Oliver Blankenstein

  37. Positive correlation of thyroid hormones and serum copper in children with congenital hypothyroidism

    Article • Journal of Trace Elements in Medicine and Biology, September 2016, Elsevier

    Professor Lutz Schomburg, Oliver Blankenstein

  38. Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist

    Article • New England Journal of Medicine, July 2016, New England Journal of Medicine (NEJM/MMS)

    Oliver Blankenstein

  39. Role of 68Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study

    Article • European Journal of Nuclear Medicine and Molecular Imaging, February 2016, Springer Science + Business Media

    Oliver Blankenstein

  40. Neuroendokrine Tumoren

    Article • January 2016, Springer Science + Business Media

    Oliver Blankenstein

  41. Congenital Adrenal Hyperplasia with Non-functional Mutations in Both Alleles in a Clinically Unaffected Infant

    Article • Journal of Tropical Pediatrics, December 2015, Oxford University Press (OUP)

    Oliver Blankenstein

  42. Normative Thyroid-Stimulating Hormone Values for Healthy Nigerian Newborns

    Article • Hormone Research in Paediatrics, December 2015, Karger Publishers

    Oliver Blankenstein

  43. Development and Testing in Healthy Adults of Oral Hydrocortisone Granules With Taste Masking for the Treatment of Neonates and Infants With Adrenal Insufficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2015, Endocrine Society

    Oliver Blankenstein

  44. Management and interpretation of heterogeneous observational data: Using insulin-like growth factor-I data from the NordiNet® International Outcome Study

    Article • Growth Hormone & IGF Research, February 2015, Elsevier

    Oliver Blankenstein

  45. Neugeborenenscreening: ein Paradebeispiel für effektive Sekundärprävention

    Article • Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, December 2014, Springer Science + Business Media

    Oliver Blankenstein

  46. Towards the Development of Smart and Reliable Health Assistance Networks Exemplified by an Apnea Detection System

    Article • September 2014, Institute of Electrical & Electronics Engineers (IEEE)

    Oliver Blankenstein

  47. Occurrence of giant focal forms of congenital hyperinsulinism with incorrect visualization by18F DOPA-PET/CT scanning

    Article • Clinical Endocrinology, May 2014, Wiley

    Oliver Blankenstein

  48. Development of oral hydrocortisone granules with taste masking for the treatment of neonates and infants with adrenal insufficiency

    Article • Endocrine Abstracts, April 2014, Bioscientifica

    Oliver Blankenstein

  49. Medication safety study investigating hydrocortisone individually and extemporaneously compounded capsules for paediatric use in congenital adrenal hyperplasia

    Article • Endocrine Abstracts, April 2014, Bioscientifica

    Oliver Blankenstein

  50. Hyperinsulinaemic Hypoglycaemia

    Article • Hormone and Metabolic Research, February 2014, Thieme Publishing Group

    Oliver Blankenstein

  51. European Society for Paediatric Endocrinology Consensus Guidelines on Screening, Diagnosis, and Management of Congenital Hypothyroidism

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2014, Endocrine Society

    Oliver Blankenstein

  52. Incidence of sickle cell disease in an unselected cohort of neonates born in Berlin, Germany

    Article • European Journal of Human Genetics, January 2014, Springer Science + Business Media

    Oliver Blankenstein

  53. Hydrocortisone Replacement in Disorders of Sex Development

    Article • January 2014, Karger Publishers

    Oliver Blankenstein

  54. Data-Dependent Controller Synthesis to Enable Reliable and Safe Interoperability of Medical Devices

    Article • January 2014, Institute for Computer Sciences, Social Informatics and Telecommunications Engineering (ICST)

    Oliver Blankenstein

  55. Newborn Screening for Sickle Cell Disease: Technical and Legal Aspects of a German Pilot Study with 38,220 Participants

    Article • BioMed Research International, January 2014, Hindawi Publishing Corporation

    Oliver Blankenstein

  56. Zum aktuellen Stand der Kindervorsorgeprogramme

    Article • Das Gesundheitswesen, January 2013, Thieme Publishing Group

    Oliver Blankenstein

  57. Two Novel GATA6 Mutations Cause Childhood-Onset Diabetes Mellitus, Pancreas Malformation and Congenital Heart Disease

    Article • Hormone Research in Paediatrics, January 2013, Karger Publishers

    Oliver Blankenstein

  58. Comparison of response to 2-years’ growth hormone treatment in children with isolated growth hormone deficiency, born small for gestational age, idiopathic short stature, or multiple pituitary hormone deficiency: combined results from two large observa...

    Article • International Journal of Pediatric Endocrinology, July 2012, Springer Science + Business Media

    Professor Lars Sävendahl, Oliver Blankenstein

  59. Does the aromatic l-amino acid decarboxylase contribute to thyronamine biosynthesis?

    Article • Molecular and Cellular Endocrinology, February 2012, Elsevier

    Oliver Blankenstein, Josef Köhrle

  60. Gender Influences Short-Term Growth Hormone Treatment Response in Children

    Article • Hormone Research in Paediatrics, January 2012, Karger Publishers

    Professor Lars Sävendahl, Oliver Blankenstein

  61. The Heterogeneity of Focal Forms of Congenital Hyperinsulinism

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2012, Endocrine Society

    Oliver Blankenstein

  62. Long-Term Lanreotide Treatment in Six Patients with Congenital Hyperinsulinism

    Article • Hormone Research in Paediatrics, January 2012, Karger Publishers

    Oliver Blankenstein

  63. Diabetes caused by insulin gene (INS) deletion: clinical characteristics of homozygous and heterozygous individuals

    Article • European Journal of Endocrinology, August 2011, Oxford University Press (OUP)

    Oliver Blankenstein

  64. Long-Term GH Treatment Response in Short Children Born SGA Is Comparable to That in GHD Children: Data from the NordiNet® IOS

    Article • June 2011, Endocrine Society

    Oliver Blankenstein

  65. Intraoperative Sonography: A Technique for Localizing Focal Forms of Congenital Hyperinsulinism in the Pancreas

    Article • Ultraschall in der Medizin - European Journal of Ultrasound, February 2011, Thieme Publishing Group

    Oliver Blankenstein

  66. Positron emission tomography/computed tomography diagnostics by means of fluorine-18-L-dihydroxyphenylalanine in congenital hyperinsulinism

    Article • Seminars in Pediatric Surgery, February 2011, Elsevier

    Oliver Blankenstein

  67. Visualization of the focus in congenital hyperinsulinism by intraoperative sonography

    Article • Seminars in Pediatric Surgery, February 2011, Elsevier

    Oliver Blankenstein

  68. Familial Focal Congenital Hyperinsulinism

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2011, Endocrine Society

    Oliver Blankenstein

  69. Neuroendokrine Tumoren

    Article • January 2011, Springer Science + Business Media

    Oliver Blankenstein

  70. Harmonization of growth hormone measurements with different immunoassays by data adjustment

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2011, De Gruyter

    Oliver Blankenstein

  71. The predictive value of preoperative fluorine-18-l-3,4-dihydroxyphenylalanine positron emission tomography–computed tomography scans in children with congenital hyperinsulinism of infancy

    Article • Journal of Pediatric Surgery, January 2011, Elsevier

    Oliver Blankenstein

  72. Treating patients not numbers: the benefit and burden of lowering TSH newborn screening cut-offs

    Article • Archives of Disease in Childhood, July 2010, BMJ

    Oliver Blankenstein

  73. Congenital hyperinsulinism

    Article • Early Human Development, May 2010, Elsevier

    Oliver Blankenstein

  74. P31 Earlier start of puberty in GH treated children born SGA than in GH treated for GHD. Data from the NordiNet® IOS

    Article • Growth Hormone & IGF Research, January 2010, Elsevier

    Professor Lars Sävendahl, Oliver Blankenstein

  75. Gründung der Sektion „Endokrinologische Laboratoriumsdiagnostik“ der DGKL

    Article • LaboratoriumsMedizin, January 2010, De Gruyter

    Oliver Blankenstein

  76. Congenital hyperinsulinism: [18F]DOPA PET/CT scan of a focal lesion in the head of the pancreas

    Article • BMJ Case Reports, February 2009, BMJ

    Oliver Blankenstein

  77. Sedierung von Kindern zum PET-CT bei kongenitalem Hyperinsulinismus

    Article • Der Anaesthesist, August 2008, Springer Science + Business Media

    Oliver Blankenstein

  78. Gelbfärbung der Haut, Muskelschwäche und Niereninsuffizienz

    Article • Monatsschrift Kinderheilkunde, April 2008, Springer Science + Business Media

    Oliver Blankenstein

  79. Evaluation of [18F]Fluoro-l-DOPA Positron Emission Tomography-Computed Tomography for Surgery in Focal Congenital Hyperinsulinism

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2008, Endocrine Society

    Oliver Blankenstein

  80. EDTA in Dried Blood Spots Leads to False Results in Neonatal Endocrinologic Screening

    Article • Clinical Chemistry, March 2008, Oxford University Press (OUP)

    Oliver Blankenstein

  81. Height Gain with Combined Growth Hormone and Gonadotropin-Releasing Hormone Analog Therapy in Two Pubertal Siblings with a Growth Hormone-Releasing Hormone Receptor Mutation

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2008, Endocrine Society

    Oliver Blankenstein

  82. Long-Term Non-Surgical Therapy of Severe Persistent Congenital Hyperinsulinism with Glucagon

    Article • Hormone Research in Paediatrics, January 2008, Karger Publishers

    Oliver Blankenstein

  83. [<sup>18</sup>F]-DOPA Positron Emission Tomography for Preoperative Localization in Congenital Hyperinsulinism

    Article • Hormone Research in Paediatrics, January 2008, Karger Publishers

    Oliver Blankenstein

  84. Early Glibenclamide Treatment in Newborns with KCNJ11 Gene Mutation

    Article • Diabetes Care, October 2007, American Diabetes Association

    Oliver Blankenstein

  85. Congenital hyperinsulinism: [18F]DOPA PET/CT scan of a focal lesion in the head of the pancreas

    Article • Archives of Disease in Childhood Fetal & Neonatal, July 2007, BMJ

    Oliver Blankenstein

  86. Hyperinsulinaemic hypoglycaemia: biochemical basis and the importance of maintaining normoglycaemia during management

    Article • Archives of Disease in Childhood, July 2007, BMJ

    Oliver Blankenstein

  87. Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review

    Article • Intensive Care Medicine, March 2006, Springer Science + Business Media

    Oliver Blankenstein

  88. Molecular Mechanisms of Neonatal Hyperinsulinism

    Article • Hormone Research in Paediatrics, January 2006, Karger Publishers

    Oliver Blankenstein

  89. Proposal for a Standardized Protocol for <sup>18</sup>F-DOPA-PET (PET/CT) in Congenital Hyperinsulinism

    Article • Hormone Research in Paediatrics, January 2006, Karger Publishers

    Oliver Blankenstein

  90. Auffällige Fazies mit Mikrozephalie bei intrauteriner Clozapinexposition

    Article • Monatsschrift Kinderheilkunde, November 2005, Springer Science + Business Media

    Oliver Blankenstein

  91. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity -- a problem that is no longer restricted to minority groups

    Article • European Journal of Endocrinology, August 2004, Oxford University Press (OUP)

    Oliver Blankenstein

  92. Congenital disorder of glycosylation type 1a in a macrosomic 16-month-old boy with an atypical phenotype and homozygosity of the N216I mutation

    Article • European Journal of Pediatrics, August 2003, Springer Science + Business Media

    Oliver Blankenstein

  93. Longitudinal Imaging Reveals Pituitary Enlargement Preceding Hypoplasia in Two Brothers with Combined Pituitary Hormone Deficiency Attributable to PROP1 Mutation

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2001, Endocrine Society

    Oliver Blankenstein

  94. A New C-Terminal Located Mutation (V272ter) in the <i>PIT-1 </i>Gene Manifesting with Severe Congenital Hypothyroidism

    Article • Hormone Research in Paediatrics, January 2001, Karger Publishers

    Oliver Blankenstein

  95. Genetic Defects during Later Stages of Pituitary Development: The Clinical Phenotype of Pit-1 and Prop-1 Mutations

    Article • Clinical Pediatric Endocrinology, January 2001, Japanese Society for Pediatric Endocrinology

    Oliver Blankenstein

  96. Hormonelle Wachstumsstörungen

    Article • January 2000, Springer Science + Business Media

    Oliver Blankenstein

  97. Idiopathic Growth Hormone Deficiency: A Vanishing Diagnosis?

    Article • Hormone Research in Paediatrics, January 2000, Karger Publishers

    Oliver Blankenstein

  98. Molecular characterization of the cfb gene encoding group B streptococcal CAMP-factor

    Article • Medical Microbiology and Immunology, November 1994, Springer Science + Business Media

    Oliver Blankenstein

  99. Planungsunterstützung für Pankreasoperationen bei Hyperinsulinismus von Kindern

    Article • Springer Science + Business Media

    Oliver Blankenstein